IFNG and neoplasm: Interestingly, the antitumor effect of tumor antigen-loaded DCs plus lenalidomide showed the highest number of IFN-γ-secreting splenocytes against MC-38 cells and YAC-1 cells compared with the PBS control, tumor antigen-loaded DCs or lenalidomide alone (P < 0.05; Figure 3A).